Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Blood Platelet Disorders D001791 12 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Purpura, Schoenlein-Henoch D011695 5 associated lipids
Behcet Syndrome D001528 7 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Migraine Disorders D008881 11 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Thrombasthenia D013915 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Uveitis D014605 14 associated lipids
Byssinosis D002095 11 associated lipids
Enteritis D004751 8 associated lipids
Pneumonia, Aspiration D011015 3 associated lipids
Periapical Periodontitis D010485 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Arthus Reaction D001183 8 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Kiberd BA The functional and structural changes of the glomerulus throughout the course of murine lupus nephritis. 1992 J. Am. Soc. Nephrol. pmid:1450369
Fujii S et al. L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. 2003 Hypertension pmid:14504257
Vani G et al. Histone H1 modulates immune status in experimental breast cancer. 2003 Chemotherapy pmid:14504437
Tanaka Y et al. Effects of exercise on platelet and aortic functions in aged rats. 2003 Acta Physiol. Scand. pmid:14510779
Rossoni G et al. Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats. 2003 Eur. J. Pharmacol. pmid:14512099
Beck-Speier I et al. Sulfur-related air pollutants induce the generation of platelet-activating factor, 5-lipoxygenase- and cyclooxygenase-products in canine alveolar macrophages via activation of phospholipases A2. 2003 Prostaglandins Other Lipid Mediat. pmid:14518563
Takase B et al. Effect of diltiazem on silent ischemic episodes, plasma bradykinin and prostaglandin metabolism. 1992 Int. J. Cardiol. pmid:1452374
Peng W et al. Effects of sustained ligustrazine on hemorrheology in patients with chronic pulmonary heart disease. 1992 J. Tongji Med. Univ. pmid:1453503
Rota S et al. Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis. 1992 Kidney Int. pmid:1453591
Li JS et al. [Change in intestinal free radical and prostaglandin metabolism in the aged rats with pneumococcus pneumonia]. 2003 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:14552688
Dotevall A et al. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. 1992 Thromb. Haemost. pmid:1455405
Kivioja A et al. Platelet activation during acute phase after multiple trauma. 1992 Ann Chir Gynaecol pmid:1456710
Pearl JM et al. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. 1992 Nov-Dec J. Heart Lung Transplant. pmid:1457432
Wolfram RM et al. Narghile (water pipe) smoking influences platelet function and (iso-)eicosanoids. 2003 Life Sci. pmid:14575812
Nagano H et al. Effects of a human urinary kininogenase (SK-827) on cerebral microcirculation after glass bead-induced cerebral embolism in rabbits. 1992 Sep-Oct In Vivo pmid:1457742
Chouinard ML et al. Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients. 1992 Clin. Pharmacol. Ther. pmid:1458769
Resnick DK et al. Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. 2001 Nov-Dec Spine J pmid:14588301
Resnick DK et al. Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury. 2001 Nov-Dec Spine J pmid:14588302
Kankuri E et al. Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. 2003 Thromb. Res. pmid:14592552
Zhang C et al. Inflammation is involved in the organ damage induced by sinoaortic denervation in rats. 2003 J. Hypertens. pmid:14597858
Wang ZF et al. The role of inflammatory mediators in severe acute pancreatitis and regulation of glucocorticoids. 2003 HBPD INT pmid:14599960
De León EJ et al. A new chloroquinolinyl chalcone derivative as inhibitor of inflammatory and immune response in mice and rats. 2003 J. Pharm. Pharmacol. pmid:14604476
Tanaka S et al. High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. 2003 Chest pmid:14605047
Dong WG et al. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. 2003 World J. Gastroenterol. pmid:14606091
von Aulock S et al. Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. 2004 J. Pharmacol. Exp. Ther. pmid:14610236
Yokoyama Y et al. Role of thromboxane in producing portal hypertension following trauma-hemorrhage. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14613921
Grekas D et al. Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents. 1992 Ren Fail pmid:1462000
Ohsaki S et al. Effect of prostaglandin E1 on graft function of kidneys from living related donors. 1992 Transpl. Int. pmid:14621746
Schütz A et al. Allogeneic heart transplantation following xenogeneic bridging. 1992 Transpl. Int. pmid:14621808
Yamada K et al. New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: the relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney. 1992 Transpl. Int. pmid:14621878
Mennander A et al. Chronic rejection of rat aortic allografts: effect of inhibition of the thromboxane cascade. 1992 Transpl. Int. pmid:14621882
Lyck F et al. [Thrombocyte aggregation and serum thromboxane B2 in patients with unstable angina pectoris treated with diltiazem or verapamil]. 1992 Ugeskr. Laeg. pmid:1462402
Tsipas G and Morphake P Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity. 2003 J. Nutr. Biochem. pmid:14629893
Moriguchi A et al. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban. 2004 J. Pharmacol. Exp. Ther. pmid:14634048
Yi H et al. [Protective effect of selective cyclooxygenase-2 inhibitor on alcohol-induced liver injury in rats]. 2003 Zhonghua Gan Zang Bing Za Zhi pmid:14636441
Terres W et al. Prevalence and mechanism of streptokinase-induced platelet stimulation. Effect of acetylsalicylic acid. 1992 Eur. Heart J. pmid:1464340
De Keijzer MH and Provoost AP Effect of protein intake and unilateral nephrectomy on renal function and eicosanoid excretion in rats. 1992 Miner Electrolyte Metab pmid:1465043
Eder K et al. Conjugated linoleic acids lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. 2003 J. Nutr. pmid:14652352
Minuz P et al. Determinants of platelet activation in human essential hypertension. 2004 Hypertension pmid:14656953
Petric R et al. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition. 1992 Transplantation pmid:1465778
Eldar M et al. Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery. 1992 Am. J. Cardiol. pmid:1466338
Xia Z et al. Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. 2003 J. Thorac. Cardiovasc. Surg. pmid:14666012
Böhm E et al. 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. 2004 J. Biol. Chem. pmid:14668348
Arrebola MM et al. In vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis. 2004 J. Cardiovasc. Pharmacol. pmid:14668571
Freitas CF et al. Role of endothelin-1 and thromboxane A2 in the pulmonary hypertension induced by heparin-protamine interaction in anesthetized dogs. 2004 J. Cardiovasc. Pharmacol. pmid:14668575
Sánchez-Muniz FJ et al. Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein. 2003 Eur J Nutr pmid:14673602
Lin YL and Wang CT Activation of human platelets by the rabbit anticardiolipin antibodies. 1992 Blood pmid:1467520
Sheu JR et al. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments. 2003 Exp. Biol. Med. (Maywood) pmid:14681547
de La Puerta Vázquez R et al. Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. 2004 Metab. Clin. Exp. pmid:14681843
Gutiérrez Díaz JA et al. Interaction of platelets with subendothelium in rats treated with PCA-4230, a new antithrombotic agent. Effect of PCA-4230 on experimental thrombosis. 1992 Haemostasis pmid:1468723